BEIJING, Sept. 24, 2016
/PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord
Medical" or the "Company") (NYSE: CCM), a leading specialty
hospital management solution provider and operator of the largest
network of radiotherapy and diagnostic imaging centers in
China, is pleased to announce that
its subsidiary, Medstar (Shanghai)
Leasing Co., Ltd, has signed a contract with IBA (Ion Beam
Applications S.A.) for the purchase, installation and maintenance
of a proton therapy system, which will be installed at Beijing
Proton Medical Center.
The Beijing Proton Medical Center is jointly developed by
Concord Medical and China-Japan Friendship Hospital. The
construction is expected to commence in this quarter. The center
will be equipped with IBA's Proteus®PLUS four room configuration,
including three gantry-rooms and one fix-beam room. All rooms will
be equipped with IBA's next generation Pencil Beam Scanning
capability.
Dr. Jianyu Yang, Chairman and
Chief Executive Officer of Concord Medical, commented, "We are
delighted to see Beijing Proton Medical Center has made a
significant breakthrough after so much efforts had been made in
these years. It is Concord Medical's first proton therapy center in
China and we are glad to have IBA
as our equipment vendor. Our partner, China-Japan Friendship
Hospital, is a well-known general hospital in Beijing, with outstanding scientific research
ability and nationwide brand awareness. Going forward, we will
learn from the experience and technology from other advanced proton
centers in the world and are committed to providing the best
treatment for the cancer patients in China. By carrying out joint clinical research
projects with oversea peers, we hope to achieve more academic
breakthrough in proton cancer therapy research. "
Olivier Legrain, Chief Executive
Officer of IBA commented, "We are delighted to be enhancing our
presence in China, another
important indication of the appeal of our offering in the emerging
markets. We are also pleased to be supporting Concord Medical to
advance its vision of bringing proton therapy to more patients in
China. IBA's proton therapy
technology has been used to treat more cancer patients than any
other company in the world. This extensive experience and knowledge
of proton therapy treatment has allowed IBA to ensure that more
patients are able to access this highly accurate form of cancer
treatment."
About Concord Medical
Concord Medical Services
Holdings Limited is a leading specialty hospital management
solution provider and operator of the largest network of
radiotherapy and diagnostic imaging centers in China. As of June 30,
2016, the Company operated a network of 123 centers with 73
hospital partners that spanned 52 cities and 25 provinces and
administrative regions in China.
Under long-term arrangements with top-tier hospitals in
China, the Company provides
radiotherapy and diagnostic imaging equipment and manages the daily
operations of these centers, which are located on the premises of
its hospital partners. The Company also provides ongoing training
to doctors and other medical professionals in its network of
centers to ensure a high level of clinical care for patients. As
part of its high-end cancer hospital development strategy and
oversea business extension, the Company acquired Concord Cancer
Hospital, a private hospital in Singapore in April, 2015. For more
information, please see http://ir.concordmedical.com.
About Beijing Proton Medical Center
The Beijing
Proton Medical Center is jointly-developed by Concord Medical
Services and the China-Japan Friendship Hospital. The 5,000 square
meters, international-standards medical facility will be equipped
with radiotherapy and diagnostic equipment including proton therapy
system, linear accelerator, and PET-CT. It will also provide
inpatient services to meet patients' specific needs. Concord
Medical is committed to providing the patients with the most
reliable and comprehensive cancer radiotherapy in China.
About IBA
IBA (Ion Beam Applications S.A.) is a global
medical technology company focused on bringing integrated and
innovative solutions for the diagnosis and treatment of cancer. The
company is the worldwide technology leader in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA's proton therapy solutions are
flexible and adaptable, allowing customers to choose from universal
full-scale proton therapy centers as well as compact, single room
systems. In addition, IBA also has a radiation dosimetry business
and develops particle accelerators for the medical world and
industry.
For more information, please contact:
Concord Medical Services
Ms. Fang Liu (Chinese and English)
+86 10 5903 6688 (ext. 639)
fang.liu@concordmedical.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/concord-medical-announces-to-install-proton-therapy-system-at-beijing-proton-medical-center-300333574.html
SOURCE Concord Medical Services Holdings Limited